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Abstract
Minimally Invasive Surgery (MIS) for esophageal carcinoma has improved the outcome 
of patients. This approach has been shown to decrease the rate of respiratory complica-
tions, the intensive care unit (ICU) stay, and to allow a faster recovery of patients. Also, 
an improvement in perioperative care has contributed to better outcomes compared to 
the open approach. MIS has been shown to be as safe as open surgery in terms of resect-
ability, harvested lymph nodes, and overall survival.
Keywords: esophageal carcinoma, anesthesia, minimally invasive esophagectomy,  
thoraco scopic esophagectomy, laparoscopic esophagectomy, surgical technique, prone 
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1. Introduction
Neoplasm of the esophagus is one of the most aggressive diseases with poor survival rate 
despite of the improvements in staging procedures, multimodality treatments, supportive 
care, and surgical techniques. It is the eighth most common cause of cancer and the sixth 
leading cause of cancer death worldwide [1]. Patients often are diagnosed at an advanced 
stage with metastatic disease in more than 50% at the time of presentation. Surgery is the gold 
standard for treatment both for early stage disease and for advanced disease after chemo-
radiotherapy neoadjuvant treatment. Surgery of esophageal cancer is probably one of the 
most demanding and challenging procedure for the surgeon and the patient alike—with a 
significant morbidity and mortality, particularly in inappropriately selected patients. Surgical 
treatment must consist on a radical R0 en-bloc esophagectomy associated with a two-field 
lymphadenectomy [2].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Traditionally, open approaches have been used to resect esophageal cancer, performed by 
transhiatal, transthoracic, or combined approach. Esophagectomy is a complex challenge for 
the surgeon, dealing with wide areas of the neck, mediastinum, and abdomen. Open esoph-
agectomy is considered to be one of the most traumatic oncologic procedures performed 
in gastrointestinal surgery because of the extent of resection and dissection required [3]. It 
entails a significant risk of morbidity (at least a half of patients develop complications) and 
mortality, that ranges from 6–7% in high-volume centers to 20–28% in low-volume centers.
Orringer et al. [4] reported a large series of 1085 patients who underwent open esophagec-
tomy by transhiatal approach, which has served as a standard to compare postoperative out-
comes: hospital mortality rate of 4%; 53% of patients were discharged by 10th postoperative 
day; and an anastomotic leak rate of 13%. The most frequently reported complications of open 
approach have been pneumonia (21%), respiratory failure (16%), prolonged ventilatory sup-
port more than 48 h (22%), according to the report published by Bailey et al. [5].
In an attempt to avoid extensive tissue aggression and reduce the high morbidity and mor-
tality, the minimal invasive approach has been introduced in the field of gastroesophageal 
surgery [6]. Cuschieri et al. [7] and DePaula et al. [8] were the first to apply a laparoscopic 
approach to patients with esophageal cancer. Cuschieri et al. performed six subtotal endo-
scopic esophagectomies through a right thoracoscopic approach with a mean duration of stay 
in the ICU of 19 h (range 16–26 h) and a median hospital stay of 11 days (8–18 days). DePaula 
et al. reported a small series of 12 patients who underwent transhiatal esophagectomy con-
ducted by videolaparoscopy with no mortality and minimal blood loss.
Thanks to the improvements in technology and instrumentation, as well as the surgeons’ train-
ing in advanced minimally invasive procedures, the practice of this technique has been extended 
since the 1990s. There are several single institution series reports [7–10] (retrospective and pro-
spective) comparing Minimally Invasive Esophagectomy (MIE) versus open surgery [11, 12], 
and recent meta-analyses [13, 14] that have confirmed the safety and feasibility of the procedure 
and the advantages of minimally invasive surgery. These reports show that MIE can reduce the 
mortality and morbidity of open operations as well as allow a faster recovery. All these findings 
have been confirmed at the only available level I evidence study, the TIME-trial [15].
2. Patient selection
Tumor staging is essential for planning surgical treatment, and surgery should not be per-
formed for patients without a chance of cure, such as those with distant metastases, or in 
those unable to survive the physiologic insult of the operation. The main objective of sur-
gery must be to achieve a R0 resection. Nowadays, neoadjuvant chemoradiation plays a 
key role because it downstages the tumor and allows an adequate micro and macroscopic 
tumoral resection. From a surgical perspective, the drawback is that it may further compli-
cate the procedure by distorting the peri-esophageal microanatomy and by causing a signifi-
cant postradiation fibrosis. Tissue plane may be unclear and surgery will not be easy in this 
situation.
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The difficult dissection as a result of neoadjuvant therapy and surgeons’ fear to use a mini-
mally invasive approach in advanced tumors, especially during their learning curve, cause an 
important discussion about MIE effectiveness in these situations. In a multicenter, open-label, 
randomized controlled trial published in 2012 by Biere et al. [15] that compares open surgery 
with MIE in advanced tumors, both with a similar number of patients, did not show sig-
nificant differences between both in terms of margins resection. Thus, the minimally invasive 
approach would not be a contraindication in advanced stages. However, a previous history 
of abdominal or thoracic surgeries due to a significant underlying adhesion process could 
represent a real hindrance for minimally invasive technique.
3. Evaluation of physiological reserve
Predicting which patients are going to develop complications is not easy. Even so, we must 
know which indicators can increase postoperative morbidity and mortality. Many risk factors 
have been identified: Karnofsky score less than 80, liver cirrhosis, chronic obstructive pulmo-
nary disease (COPD), ischemic heart disease, advanced age, locally advanced tumor, active 
smoking, alcoholism, and malnutrition [16–19] are some of them. Evaluating individual risk 
is important for patient selection and a proper preoperative management, regardless of the 
surgical approach to be performed (MIE or open surgery). However, there are physiological 
conditions of patients that cannot be improved.
The risk factors suggestive of preoperative optimization are the following:
• In cases of COPD, the use of long-acting β-agonists, combined with inhalated steroids [20, 
21] and preoperative inspiratory muscle training, may reduce postoperative pulmonary 
complications [22].
• If significant coronary ischemia is discovered in perioperative time, coronary revascular-
ization with angioplasty and stenting could be performed, although antiplatelet agents 
prescribed after this technique could delay esophagectomy.
• Alcoholism and smoking—The UK National Institute for Health and Clinical Excellence 
(NICE) recommends the use of nicotine as a replacement therapy for smokers to help stop 
smoking, because smoking is associated with higher risk of 30-day mortality and serious 
postoperative complications [23].
• Malnutrition is considered an independent risk factor that influences the development of 
postoperative infections, mortality, length of stay, and hospital costs in patients under-
going surgery [24]. We must bear in mind that most patients with esophageal neoplasia 
have difficulties for an adequate intake, which generates poor nutritional status and immu-
nosuppression. Therefore, patients with nutritional risk screening (NRS) score ≥3 should 
have an optimized nutritional support that includes both enteral nutrition to maintain the 
intestinal barrier function and parenteral nutrition to avoid malnutrition and infection due 
to long-term insufficient feeding. These measures will help to improve clinical outcomes in 
these patients [25, 26].
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• Patients who have a Forced Expiratory Volume in one second (FEV 1) < 70% of the pre-
dicted normal in the pulmonary function tests with normal arterial gas blood measure-
ments are considered of moderate risk and those with FEV 1 < 50% or if the arterial gas 
bold analysis show hypoxemia or carbon dioxide retention must be considered of high risk.
• Patients with Child C stage cirrhosis must not be eligible for surgery.
4. Anesthetic challenges of MIE
The anesthetic challenges of MIE include prolonged surgery, difficulties of lung isolation, 
and one lung ventilation (OLV) when patient is positioned right up and complications related 
to extraperitoneal CO
2
. Pain relief has been described as a protective factor to avoid postop-
erative respiratory complications, so it is highly recommended to use regional techniques 
for reducing postoperative pain. Also, the amount of fluids administered perioperatively can 
lead to the development of pulmonary complications and should be adequately evaluated to 
avoid fluid overload.
4.1. Prolonged surgery
MIE is a long procedure and may extend at least 5–6 h, depending on the experience of the sur-
geon. Such prolonged surgery increases the risk of hypothermia which can lead to reduce oxy-
gen delivery and increase myocardial work, stress response, and postoperative infection. Our 
main objective is to maintain normothermia. If at the end of the surgery the patient is normo-
thermic, extubation will be possible and postoperative ventilation will not be  necessary [27].
Balanced anesthesia, by an inhalation approach (sevoflurane and desflurane) or by propo-
fol target-controlled infusion with remifentanil, may help promote early recovery after MIE. 
There is evidence that both sevoflurane and desflurane, when compared with propofol, pro-
duce a beneficial local immunomodulatory effect in patients undergoing OLV for thoracic 
surgery, significantly reducing inflammatory mediators, adverse postoperative events, and 
improving clinical outcomes [28, 29].
4.2. One lung ventilation
MIE with a patient in right up position requires a period of one lung ventilation during the 
mobilization of thoracic esophagus. Inadequately managed lung isolation contributes to mor-
tality and morbidity [30].
When surgery is performed thoracoscopically, retraction of an inadequately collapsed lung 
or lobe results more difficult than in open surgery, and this is important when choosing the 
method used to achieve lung isolation. The options described to reach an adequate lung iso-
lation are a left or right double lumen tube or a single lumen tracheal tube and a bronchial 
blocker. A retrospective study has not found differences in intraoperative hypoxemia, hyper-
capnia, and high airway pressures whether a left- or right-sided tube was placed for OLV [31]. 
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As a consequence most MIE techniques involve access to the right thorax; a left double-lumen 
tube perhaps would be preferable, especially when the thoracic approach is done in lateral 
decubitus. If we used the prone position (PP), a single-lumen endotraqueal tube is a valid 
alternative. Whichever method of lung isolation is selected, a fiberoptic bronchoscope should 
be used to check correct positioning both after intubation and after moving the patient before 
surgery [32].
The combination of OLV and esophageal surgery results in an inflammatory response that will 
increase alveolar injury, leading to the development of acute lung injury (ALI) [33]. During 
and after OLV, the alveolar concentrations of IL-6 and IL-8 are increased. The lung protective 
ventilatory strategy can reduce airway pressure and airway resistance. It can decrease the 
release of IL-6 and IL-8 and inhibit lung inflammatory response during OLV and postopera-
tively [34]. Some of the consequences that may cause ventilator-induced lung injury are volu-
trauma (high tidal volume), barotrauma (excessive transpulmonary pressure), atelectrauma 
(repeated opening and closing of alveoli resulting), and biotrauma (caused by inflammatory 
mediators) [35].
Thus, it is essential for the implementation of protective ventilatory strategies to reduce the 
severity of lung injuries during mechanical ventilation. These strategies include restrict tidal 
volume to 5–6 ml/kg during OLV, optimizing positive expiratory end pressure (PEEP), and lim-
iting plateau and peak inspiratory pressures to less than 25 cm H
2
O and less than 35 cm H
2
O, 
respectively [36]. In addition to reduce lung injury, these actions promote early extubation [37].
4.3. Complications of extra-peritoneal carbon dioxide
MIE may require a large period of capnoperitoneum, while laparoscopic dissection and mobi-
lization of the stomach are being performed. As a consequence of surgical communication 
between the chest and abdomen, carbon dioxide may pass into the right chest, where drain 
tube has been placed in thoracic step, and this gas can be vented by this drain. In this situ-
ation, laparoscopic abdominal dissection could be difficult. Moreover, carbon dioxide may 
diffuse into the mediastinum (capnomediastinum), into the left chest, and it can cause subcu-
taneous emphysema around the chest, axilla, and neck. We can realize that gas is spreading to 
these spaces if we object a rapid increase in end-tidal CO
2
. If CO
2
 is accumulated inside thorax 
cavity, an increase of airway pressures and lung compression might occur, leading to oxygen 
desaturation. This fact could negatively affect cardiac output.
We can solve all these problems by reducing the pressure at which the capnoperitoneum is 
maintained, and this will reduce the diffusion of gas to thoracic cavity without impairing 
abdominal dissection. Anyway, if extra-abdominal CO
2
 compromises cardiac or respiratory 
function, the capnoperitoneum should be evacuated. We should not extubate patients with 
significant emphysema until we achieve normocarbia [27].
4.4. Fluid management—goal directed therapy (GDT)
Maintaining adequate fluid balance is essential in both open surgery and MIE. While excessive 
fluid administration may be associated with increased postoperative pulmonary  complication, 
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tissue edema, and compromised perfusion, an inadequate intravascular volume can predis-
pose to ischemia, end-organ dysfunction, and risk of anastomotic failure and leak.
In esophagectomy patients, an accurate fluid balance is essential to achieve adequate perfusion 
pressure and oxygen delivery to vital organs. The form of fluid replacement therapy, which is 
currently recommended, seems to be based on the principles of goal-directed therapy (GDT) 
with the aim to increase cardiac output in high-risk surgical patients. Various studies have 
found that GDT-based fluid administration improves intraoperative hemodynamic stability 
and reduces intensive care unit admissions, the incidence of complications, and mortality [38].
Some authors have suggested that restrictive fluid therapy is preferable to fluid overload 
because it leads to improved gastrointestinal recovery time, reduced overall morbidity [39], 
improved respiratory parameters, decreased incidence of postoperative pulmonary complica-
tions and shorter recovery periods [40]. On the other hand, fluid overload causes lung injury 
and has negatively impact to intestinal anastomoses [41].
4.5. Thoracic epidural analgesia (TEA) versus paravertebral analgesia
Even with reduction in trauma access, MIE may still result in an important postoperative 
pain, and optimal multimodal analgesia is required. Effective analgesia accelerates extuba-
tion, recovery, and early mobilization. Despite the importance of regular postoperative sim-
ple analgesia, a regional technique is essential.
Thoracic epidural analgesia (TEA) offers many benefits in esophagectomy, reducing respira-
tory complications, such us pneumonia [42–44] and postoperative pain. TEA has also been 
associated with decreased incidence of anastomotic leakage [37], possibly as a consequence 
of improving microcirculation in the gastric conduit [45]. Moreover, epidural analgesia also 
decreases the risk of prolonged ventilation or reintubation and improves some lung func-
tion parameters and blood oxygenation [46]. However, TEA also has some disadvantages: the 
incidence of failure may reach 12%, there are risks in the application technique, and it does 
not only promote urinary retention but also cause hypotension which makes necessary addi-
tional fluid administration [47–49]. Contraindications to an epidural access include sepsis or 
bacteraemia, infection at the insertion site, hypovolemia or shock, coagulopathy or thrombo-
cytopenia and increased intracranial pressure [50].
Paravertebral blockade has recently been shown to provide analgesia comparable with TEA 
after thoracic step of esophagectomy. It is associated with less incidence of failed block and 
reduces hypotension and urinary retention when it is compared with TEA. Several recent 
reviews and meta-analyses defend its benefits [51–53], and it is a standard practice in some 
UK hospitals for minimally invasive esophagectomy. Local data also show shorter stays in the 
intensive therapy unit comparing with TEA.
4.6. Conclusion
MIE supposes many anesthetic challenges, some of them unique for this type of procedure 
and requires an accurate knowledge of the different surgical steps performed. Moreover, it is 
Esophageal Abnormalities40
essential to know and treat complications of one lung anesthesia and extra-peritoneal spread 
of CO
2
. Paravertebral blockade might have more benefits than TEA to improve postoperative 
pain in patients undergoing for MIE.
5. Operative technique
Minimally invasive esophageal resection for cancer involves a three-stage operation that 
includes a thoracosopy and laparoscopy, either with a cervical or intrathoracic anastomosis. 
It has been described as different combinations of laparotomy, thoracotomy, thoracoscopy, 
and laparoscopy approaches called hybrid techniques. These techniques have 1 step of the 
procedure completed via an open approach.
5.1. Thoracoscopy phase
The operation starts with thoracoscopic mobilization of the esophagus and thoracic lymph-
adenectomy. The thoracic phase can be performed through a lateral right thoracic approach 
by blocking the right tracheal bronchus, or in prone position without selecting any blocking.
In the first case, the patient is positioned in the left lateral decubitus position (LDP) and a right 
lung blocking is achieved employing a double-lumen tube. The surgeon stands on the left side 
of the patient and the assistant on the right. Three to four thoracoscopic ports are used in this 
approach and placed as follows:
• 10-mm camera port is placed at the 7th to 8th intercostal space, just anterior to the midaxil-
lary line.
• A 5-mm port is placed at the 8th or 9th intercostal space, posterior to the posterior axillary line.
• A 10-mm port is placed at the 4th intercostal space in the anterior axillary line.
• The last 5-mm port is placed just posterior to the scapula tip.
When thoracoscopy is performed in a prone position (Figure 1), the mobilization of the 
esophagus takes place with a right prone posterior approach. Patients are intubated with a 
single-lumen endotracheal tube and the right lung remains partially collapsed because of the 
positive pressure of pneumothorax created and due to the gravity. The right upper limb is 
abducted 80–100°. The surgeon stands on the right side of the patient, the first assistant (cam-
era) to the left of the surgeon, and the second assistant stands on the left side of the patient. 
Three ports are used and placed as follow:
• 10-mm camera port is placed at the 7th intercostal space below the inferior angle of the scapula.
• 5–10 mm port for right-hand working is placed at the 5th intercostal space right lateral 
from the spinous process.
• 5 mm for left-hand working is placed at the 9th intercostal space right lateral from the 
spinous process.
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Pneumothorax is created and the insufflation pressure must be maintained at 6–8 mmHg. A 
single retracting suture in the diaphragm could be used to provide downward traction allow-
ing good exposure of the distal esophagus, although in most occasions this is not necessary.
After a general survey of the tumor area and pleura, the inferior pulmonary ligament and 
the mediastinal pleura over the esophagus are divided up to the level of the azygos vein 
(Figure 2), which is sectioned with an endoscopic vascular stapler. The proximal esophagus 
is exposed and dissected circumferentially up to the level of 1–2 cm above the carina, using 
5-mm harmonic shears, from the pericardium, chest wall, descending thoracic aorta, and 
superior cava vein, including all surrounding lymph nodes (Figure 3), periesophageal tissue, 
and fat. A tape is used for retraction of the esophagus to facilitate the dissection around it. 
Any aortoesophageal vessel and any lymphatic branches must be clipped. The thoracic duct 
has to be protected. The vagal trunks are identified and divided.
The dissection should be performed near the esophagus to avoid trauma to the posterior 
membranous trachea and the recurrent laryngeal nerves, which is the most difficult step. 
Laterally, dissection is carried down to the left pleura and continues to the thoracic inlet. A 
careful lymph nodal clearance must be achieved in the supracarinal space. Mobilization of the 
distal esophagus poses no problem, and it is important to limit it in order to avoid difficulty 
in maintaining pneumoperitoneum during the abdominal phase.
After the placement of a chest tube, the right lung is allowed to expand fully (or inflated in left 
lateral decubitus approach). Some surgeons infiltrate intercostal spaces with local anesthetic. 
Trocars are removed, and ports are closed.
Figure 1. Thoracic trocar position on the right chest for thoracoscopic esophagectomy.
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5.2. Laparoscopy and cervical phase
The second stage starts turning the patient to a modified Lloyd-Davis position with reverse 
Trendelemburg and neck exposing the left cervical area. The surgeon remains between the 
legs of the patient. The first and second assistants stand to the right and to the left of the 
patient, respectively. Five abdominal ports are used for the dissection: 10-mm supraumbilical 
port for camera; 5 mm epigastric port for retraction of left lobe of the liver, 5–10 mm right mid-
clavicular port for left-hand working; 5–10 mm left midclavicular port for right-hand work-
ing; and 5–10 mm left anterior axillary port for gastric retraction. It is advisable to use trocars 
of a diameter of 10 mm for the possibility of using staplers from any port.
Figure 2. Division of the azygos vein using a stappler.
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After placement of the ports, an abdominal general survey must be performed. The gastro-
hepatic omentum is divided; the right and left crura of the diaphragm are dissected to allow 
easy passage of the gastric tube through the hiatus (preventing later gastric outlet obstruc-
tion). Left gastric artery and vein are dissected and divided using an endoscopic stapler with 
vascular load and a careful lymph node clearance over the left gastric pedicle, celiac axis, 
common hepatic, and splenic artery must be achieved. The stomach is mobilized by divid-
ing the short gastric vessels in the gastrocolic omentum, using ultrasonic coagulating shears 
taking care of preserving the right gastroepiploic arcade. The fundus is dissected from the 
superior pole of the spleen and the pancreaticogastric ligaments are divided. Authors do not 
recommend pyloroplasty since it has been widely demonstrated that this does not improve 
gastric emptying.
Then the gastric tube is constructed with the stapler by dividing the stomach starting at the 
lesser curve. The construction of the gastric tube may vary depending on the characteristics 
of the tumor (if the tumor is located in the gastroesophageal junction or it has gastric exten-
sion, it may be necessary to resect some of the proximal stomach and to make an intrathoracic 
anastomosis). It is preferably a gastric tube with 5–6 cm in diameter. Most of the groups place 
a feeding jejunostomy laparoscopically. Authors prefer to leave a nasojejunal feeding tube to 
avoid complications derived from a jejunostomy.
The phrenoesophageal membrane is dissected, and gastric conduit is pulled through poste-
rior mediastinum and brought up to the neck. Torsion is avoided by ensuring that the greater 
curvature always lies toward the left crus.
The last stage consists of a careful dissection of the cervical esophagus. A 4–6 cm left skin 
crease cervical incision is made. The tape looped around the esophagus left during the  thoracic 
Figure 3. Mediastinal periesophageal lymph node.
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dissection allows the surgeon to pull it out through the neck to facilitate the dissection. The 
esophagogastric specimen is pulled out of the neck incision and the esophagus is transected 
2–3 cm distal to the upper esophageal sphincter. A very high anastomosis is performed 
between the cervical esophagus and gastric tube in an end-to-end manner using an End-to-
end anastomosis stapler (EEA sta-pler) or something similar. Some groups suture the gastric 
conduit to the prevertebral fascia. Neck wound is closed and a cervical drain could be placed. 
To prevent hiatal herniation, laparoscopic tacking sutures between the gastric tube and the 
diaphragm should be placed. If the anastomosis is performed intrathoracicaly, cervical stage 
is not performed.
Some groups pull out the specimen through a minilaparotomy incision incorporating camera 
port, and they construct the gastric tube in an extracorporeal way. This is recommended in 
cases of bulky tumors because it facilitates extraction of the specimen and allows to achieve a 
longer gastroplasty in case of performing the anastomosis in the neck.
One tube-drain is placed close to the hiatus. Trocars are removed, and ports are closed.
6. Minimally invasive surgery versus open approaches
Minimally invasive esophagectomy emerges as an attempt to reduce the significant morbidity 
and mortality of classic open techniques and allows a faster recovery of the patient.
Different groups have reported their experience in implementation of minimally invasive sur-
gery in esophageal cancer in order to assess the potential advantages and disadvantages. One 
of the largest series was published by Luketich et al. [9]. They showed their outcomes in 222 
patients after MIE: 30-day operative mortality of 1.4%, median intensive care unit stay of 1 day 
(range 1–3), hospital stay of 7 days (range 3–75), lower incidence of pneumonia, and adult respi-
ratory distress syndrome (ARDS) (7.6 and 5%, respectively); anastomotic leak rate of 11.7%; 
and excellent health-related quality of life (HRQL) scores at a mean follow-up of 19 months, 
showing that MIE is a safety procedure and have potential advantages over open approach. 
Palanivelu et al. [10] reported their experience in 130 patients who underwent MIE with prone 
thoracoscopy: median ICU stay of 1 day (range 1–32 days), median hospital stay of 8 days (range 
4–68 days), postoperative morbidity of 20.76%, perioperative mortality of 1.54%, anastomotic 
leak rate of 2.31%, lower incidence of pneumonia, and ARDS (1.54 and 0.77%, respectively), 
minimum blood loss. Both series showed a stage-specific survival similar to an open approach.
These findings have been confirmed in a recent meta-analysis [13] of 57 studies containing 
15,790 patients with resectable esophageal cancer. Less intraoperative blood loss, short hospi-
tal stay, reduction of the incidence of total and pulmonary complications (OR: 0.700, 95% CI 
0.626–0.781 and OR: 0.527, 95% CI: 0.431–0.645, p < 0.05, respectively), and high operative time 
than Open esophagectomy were found. However, ICU stay, the number of harvested lymph 
nodes, and anastomotic leak had no significant differences.
As we have mentioned previously in this chapter, traditional open esophagectomy carries a 
significant risk of postoperative complications that involves a profound detrimental impact on 
Minimally Invasive Esophagectomy
http://dx.doi.org/10.5772/intechopen.69584
45
patient’s quality of life. Quality of life typically returns to baseline after 1 year [54]. Minimally 
invasive techniques avoid thoracoabdominal incisions and reduce the levels of tissue trauma. 
The recovery rate after minimally invasive esophagectomy seems to be faster than after open 
approach. Parameswaran et al. [11] assessed this question in a prospective longitudinal non-
randomized study in 62 patients, measuring health-related quality of life (HRQL) after MIE. 
Their study noticed that although patients reported marked deterioration in most aspects of 
HRQL 6 weeks after the operation, they started to recover by 3 months and returned to base-
line levels by 6 months, except reflux and diarrhea.
There is concern about if oncologic outcomes are equivalent to that of the open approach. 
When minimally invasive surgery was introduced in the management of colorectal cancer, 
there was also a concern about safety and oncological quality of resections. However, several 
randomized prospective trials demonstrated that the laparoscopic approach was not only safe 
but also oncologically sound [12].
While the advantages over short-term postoperative outcomes have been widely published 
by different institutions, there is a lack on the available data about oncologic efficacy and 
survival after MIE compared with the open approach. Different groups have tried to dem-
onstrate that the adequacy of surgical margins and lymphadenectomy can be maintained or 
even improved with a MIE approach [55]. Berger and colleagues [12] found in their retro-
spective review that there were no differences between the groups in the R0 resection rates 
and a significant increase in nodal harvest in the MIE group (median 20 versus 9; p < 0.0001). 
Because of the known impact of neoadjuvant treatments on lymph node yields, they also 
examined lymph node harvest by the presence or absence of neoadjuvant chemoradiation, 
and they did not find differences in both groups. However, patients in the open group had a 
more advanced stage disease, and most of them had received neoadjuvant treatments.
The same group published a later work, Palazzo et al. [56], that compares survival of patients 
undergoing MIE and open or hybrid esophagectomy (OHE) in a retrospective analysis. They 
found on Kaplan-Meyer univariate analysis, a significantly improved 5-year survival with 
MIE (MIE 64%, OHE 35%, p < 0.001) and after adjusting for potential confounding factors 
(lymph nodes harvested, neoadjuvant treatments, stage, etc.) in a multivariate analysis dem-
onstrated that patients undergoing OHE had a significantly worse survival. They made the 
same selection bias as in their previous study.
Nevertheless, these results are based on nonrandomized small series with heterogeneous data 
and could be affected by patient selection bias (frequently MIE group include a higher num-
ber of patients who have early disease stages and thus, less patients who received neoadju-
vant chemoradioteraphy). Advanced tumors and the use of neoadjuvant therapy have been 
considered to be contraindications to MIE by many surgeons and limited its use, especially in 
patients with advanced disease.
All these studies have culminated in TIME-trial published in The Lancet in 2012 by Biere et al. 
[15, 57]. It is the first randomized trial to investigate the potential advantages of minimally 
invasive esophagectomy. They undertook a multicenter, open-label, randomized controlled 
trial at five study centers in three different countries. They compared open with minimally 
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invasive esophagectomy with a right thoracoscopy in the prone position in a total of 115 
patients with resectable esophageal cancer, excluding cervical allocation. The results showed 
that significantly fewer patients had postoperatory pulmonary infections, shorter hospital stay, 
and less blood loss in the minimally invasive group than in the open group. No difference was 
found in ICU stay. Also, short-term postoperative quality of life measured by SF 36, EORTC 
C30, and esophageal-specific OES18 questionnaire were significantly better for patients in the 
minimally invasive group, and they had less pain according to the Visual Analogue Scale 
(VAS) pain score. However, pathological parameters of the resected specimen and 30-day and 
in-hospital mortality did not differ between groups. They concluded that patients undergoing 
the minimally invasive approach have short-term benefits in pulmonary infections, hospital 
stay, and quality of life outcomes with no compromise in the quality of the resected specimen.
More randomized clinical trials are needed in order to assess the long-term advantages of 
minimally invasive surgery.
7. Prone position versus lateral decubitus position for thoracic step
To minimize morbidity and mortality after an esophagectomy, a thoracoscopic approach was 
introduced as a minimally invasive option [58, 59]. This procedure is most commonly per-
formed with the patient in the left lateral decubitus position, but prone position is a valid 
alternative. Cuschieri et al. [60] first explained the prone position (PP) for thoracoscopic 
esophageal mobilization in 1994. They described this technique in 6 patients and compared 
the results with those of left lateral position in 20 patients. They suggested that PP had techni-
cal advantages and reduced postoperative complications. However, this technique was not 
widely used at that time, and more than 10 years have passed by to find publications that 
talk about PP again. In 2006, Palanivelu et al. [10] reported their experience with 130 patients 
treated by thoracoscopic esophagectomy in PP raising new interest in this procedure. Many 
reports about that have been published so far.
The primary benefit of the PP is derived from the anatomical exposure: the lung falls away as 
a consequence of gravity and the esophagus is better visualized. This permits performance of 
the operation without the need for collapsing the right lung using a double-lumen endotra-
cheal tube. If we use a single-lumen endotracheal tube, the partial or intermittent ventilation 
of the right lung reduces the venous shunt effect and results in opening up a great percentage 
of the alveoli helping in prevention atelectasis. Moreover, this type of ventilation does not make 
difficult the surgical procedure or prolong its duration. In a prone position, we have better 
functional residual capacity than in a supine position. Furthermore, ventilation perfusion ratio 
is well maintained, and hypoxia and hypercarbia are avoided. All of this, aided by gravity, 
reduces lung injury. All that was mentioned previously could explain why Cuschieri et al. [60] 
described a decrease in respiratory complications in PP. Luketich group [9] performed the 
thoracoscopic surgery in LDP and reported the incidence of pneumonia in 7.6% and adult 
respiratory distress syndrome (ARDS) in 5% of the patients. Palanivelu et al. [10] talks about 
pneumonia in 1.54% of the patients and ARDS in 0.77% with PP approach.
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As we have described already, gravity and artificial pneumothorax may improve mediastinal 
organs and structures exposure without any help of an assistant: this is another benefit of the 
PP. It makes possible the use of only three trocars, while four of them are needed in lateral 
decubitus approach. Prone position also promotes blood and other fluids from accumulat-
ing in the right anterior thorax, instead of posterior mediastinum that takes part of operative 
field. Thus, intermittent suction of accumulated fluids is not required during surgery. In the 
lateral position, the esophagus is in a dependent place and any pooling of blood obscures the 
surgical field.
Recently, Javed et al. [61] have published a comparative study between MIE in prone versus 
lateral decubitus position (LDP). They described the surgery in LDP using an additional tro-
car (four in total) for the assistant to retract the lung and to suction out the blood, whereas 
they only need three for PP technique. In this study, authors report low blood loss intraopera-
tive, which was significantly less in PP group. Kubo et al. [62] also describe significantly lower 
blood loss with this approach. This fact could be explained due to a better exposure in PP that 
allows a more meticulous dissection avoiding damage to vessels and other thoracic structures 
and decreasing bleeding.
Noshiro et al. [63] have published a study to describe whether lymphadenectomy along the 
left recurrent laryngeal nerve is facilitated in the PP. Lymph nodes along this nerve are fre-
quently involved by carcinoma cells, and their complete dissection is required [58]. They 
conclude that when PP is compared with LDP, lower blood loss and better exposure of the 
surgical field around the left recurrent laryngeal nerve occurs in first group. Although they 
describe slightly higher number of the resected lymph nodes in the PP, they do not find signif-
icant differences. On the other hand, Javed et al. [61] show a significantly higher lymph node 
yield in PP and the number of patients with affected lymph nodes is also significantly higher.
Most of the reports [10, 61] describe a shorter operative time for a thoracoscopic esophagec-
tomy in PP than in LDP. As we have said before, the best exposure of the surgical field allows 
for faster and better quality surgery.
Fabian et al. [64] suggested that the learning curve for the prone position approach appears to 
be relatively short, within the first five cases. This author also says that prone approach may 
result in better dissection into the neck explained by pneumatic dissection from the thoracic 
cavity cranially along the esophagus. This maneuver simplifies the neck surgery that could 
lead to less morbidity in cervical step.
The incidence of complications, such as anastomosis leak, gastric tip necrosis, chylothorax, 
tracheal, or vocal cord injury is comparable between PP and LDP according to many reports. 
Other clinical outcomes seem to be similar between both: median length of stay, discharged 
within 10 days, and in-hospital mortality [63, 64]. As we have commented at the beginning, it 
might be possible to reduce respiratory morbidity using PP approach.
In addition, in PP the surgeon’s wrist and shoulder joins are in a neutral position in relation to 
the forearms and upper arms, minimizing fatigue and maximizing ergonomic function. The 
view of the monitor stands parallel to operative field and ergonomic position of the surgeon 
makes easier hand-eye coordination. In contrast in LDP, the surgeon’s view of the monitor 
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must be turned upside down to avoid the counterimage when two monitors are set on each 
side. In this situation, hand-eye coordination cannot be obtained smoothly if a scope-holding 
assistant does not work correctly.
One disadvantage with the prone technique could be the need for conversion to open required 
electively when many adhesions preclude a minimally invasive approach or emergently as a 
consequence of uncontrollable bleeding. Although a posterior thoracotomy can be performed 
in this position, it is a less familiar approach that hinders dissection. Moreover, if we have 
performed the thoracic step without the use of a double-lumen endotracheal tube, we have 
to know that if a conversion is required, isolated lung ventilation would be invaluable. Thus, 
there are authors that continue using double-lumen intubation in the prone approach [64].
In conclusion, the PP may be performed with comparable outcomes to the LDP. The tech-
nique improves exposure of the operative field and reduces surgical times without compro-
mising patient's safety or oncological results. Moreover, PP brings on an ergonomic position 
for the surgeon that makes easy the dissection.
8. Fast-track surgery (FTS) protocol on patient undergoing MIE
The concept of fast-track surgery (FTS) was first introduced by Kehlet and Mogensen [65], and 
the objective of his study was to show less postoperative stress, reduce morbidity associated 
with complications, accelerate recovery, and reduce postoperative cost in patients submitted 
for colon surgery after a rehabilitation programme [66]. It is essentially a multidisciplinary 
team to perform a fast-track approach during perioperative period for reaching an optimal 
outcome [67]. To date, the fast-track protocol has been applied in many surgical fields such as 
colon, rectum, or liver, but there is limited literature talking about the safety of using this pro-
tocol in esophageal surgery, especially in those cases where a minimally invasive technique 
is going to be performed.
Patients must receive health instructions and adequate information about FTS in the preopera-
tive period. As we have explained previously, it is essential to optimize nutritional support with 
enteral and parenteral nutrition in those patients with long-term insufficient feeding and nutri-
tional deficiencies. Recall that this measure has not been carried out in conventional care [68].
Many anesthesiologists have always been wary of allowing an esophageal cancer patient to 
ingest liquids 3 h before induction of anesthesia, defending the risk of aspiration pneumo-
nia with this maneuver. But National and European Anesthesia Societies now recommend 
intake of clear fluids until 2 h before the induction of anesthesia as well as a 6 h fast for solid 
food [69]. Following these guidelines, Pan and his group, who have recently published a FTS 
protocol for MIE [70], instructed patients to drink fluid meals until 6 h before surgery and a 
carbohydrate drink until 3 h before surgery. They do not notice more pulmonary complica-
tions in FTS group than in conventional management group.
The use of the nasogastric tube (NGT) during the postoperative period is still controversial, 
although data describes disturbance of water, electrolyte, and acid base, and more digestive 
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fluid reflux using nasogastric tube, which can increase pulmonary morbidity [71]. Some stud-
ies also show that NGT can delay normal gastrointestinal function [72]. Removal of NGT in the 
immediate postoperative period promotes early oral diet introduction that has some physi-
ological advantages: decreases bacterial translocation, ensures function of intestinal mucosal 
cells, activates digestive secretory system, reduces postoperative infection, and accelerates 
organ recovery [73]. Oral feeding can be initiated during the first 48 h, following a stepwise 
programme from water to fluid meals, and finally to semifluid meals and normal food. Pan 
et al. [70] do not report gastroenterological complications, including anastomosis leak, with-
out using NGT in postoperative period, and they suggest that an early oral diet in patients 
with MIE is safe and feasible. Enteral nutrition through jejunostomy may be initiated on the 
first postoperative day, even before oral intake. Both, oral and enteral nutrition, promote 
faster recovery of gastrointestinal function. Lewis et al. [74] concluded in their meta-analysis 
that early enteral nutrition can reduce anastomosis leakage and mortality. Jejunostomy can be 
removed when patients are able to ingest normal food.
The evidence about restrictive fluid administration intraoperatively and postoperatively, as 
we have reported in section called “anesthetic challenges of MIE,” show less cardiopulmo-
nary complications with this therapy. Earlier oral and enteral nutrition promotes that post-
operative intravenous fluids can be reduced to as little as possible and removed during the 
first 24–48 h.
Abdominal and chest tube are also points of discussion in the FTS programme:
• Abdominal cavity drainage allows monitoring active bleeding and anastomosis leak, but 
it also can lead to abdominal infection and intestinal obstruction. While conventional 
care prefers to maintain drainage a few days, supporters of the fast-track protocol sug-
gest that we should not leave drainage if there is no evidence of intraoperative complica-
tions. Jesus et al. [75] do not report more mortality or morbidity without using abdominal 
drainage.
• Chest tube causes pain and limits patient's mobility, so it has to be removed as soon as pos-
sible. A recent study has showed that it is safe to remove thoracic drainage when its volume 
is between 250 and 450, and there is no air leak.
The fast-track protocol also includes early perambulation after surgery for preventing venous 
thromboembolism that can be facilitated if patients are not carrying any type of drainage. 
Adequate analgesia can also accelerate perambulation and promote the recovery of intestinal 
function. Moreover, chest physiotherapy and incentive spirometry should be instituted. In 
their study, Pan et al. [70] reported that hospital stay and the days until intestinal activity 
are significantly shortened in the FTS group without an increase in morbidity and mortality. 
Patients undergoing MIE and fast-track protocol can be discharged earlier, even in the first 
week.
In summary, FTS program can be used safely in patients undergoing MIE because it pro-
motes early recovery without increasing morbidity and mortality. We must offer the patient 
adequate preoperative information about the fast-track protocol to facilitate its implementa-
tion in the immediate postoperative period.
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9. Conclusion
The minimally invasive approach to esophageal cancer is a safe and feasible procedure with 
favorable outcomes when compared to open esophagectomy. The data available reported by the 
different studies describe fewer respiratory complications, a reduction of hospital stay and faster 
patient recovery without compromising the oncologic efficacy related with harvested lymph 
nodes and R0 margin resection. The thoracoscopic approach in prone position is an alternative 
that offers more benefits than the lateral decubitus technique. Moreover, the implementation of 
a fast-track protocol allows an early recovery without increasing morbidity and mortality.
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